Key facts
- Notable investors include IBB Ventures, Ascenion, BIH Digital Health Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for x-cardiac
- ·The full record, as it builds
Funding rounds
No funding rounds for x-cardiac are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About x-cardiac
Developer of digital biomarkers designed to predict and prevent complications after heart surgery. The company's biomarker uses big data and artificial intelligence to help in the early detection of postoperative complications in cardiac intensive care units, enabling healthcare institutions to improve the diagnosis of heart surgery.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2021
- Employees
- 5
- Website
- xcardiac.com/
- Ownership
- Privately Held (backing)
x-cardiac doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in x-cardiac shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on x-cardiac in its N-PORT filings yet. We sweep new filings monthly.